Laura J. van ’t Veer PhD

Interviews and expert commentary tagged “Laura J. van ’t Veer PhD” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Laura J. van ’t Veer PhD: Triple Negative Early Breast Cancer Genetic Sub-Types Predict No Benefit from Neoadjuvant Pembrolizumab
Audio Journal of Oncology

Laura J. van ’t Veer PhD: Triple Negative Early Breast Cancer Genetic Sub-Types Predict No Benefit from Neoadjuvant Pembrolizumab

ImPrintTN single-sample classifier identifies no benefit from deoadjuvant pembroliozumab in TNBC

28 August 2025
15:48
← Browse all episodes